Matthew Woodruff received a BS in biotechnology in 2008 from the Rochester Institute of Technology (RIT). Immediately following, he attended Harvard University as a doctoral candidate in immunology, graduating in 2014 with a thesis describing the earliest phases of immune response following influenza vaccination. In 2014, Woodruff pursued a postodoctoral fellowship at Emory University, again studying the early phases of immune response (specifically antibody selection). He published that work in 2018, and transitioned into a human immunology lab under Dr. Iñaki Sanz, specializing in the study of autoimmune diseases. Since the start of the COVID-19 pandemic, he's refocused almost entirely on studying the immune responses in patients with severe COVID-19. Woodruff is a member of the Scholars Strategy Network, and has a strong interest in public outreach.
The CDC issued an urgent health advisory for those currently pregnant, planning a pregnancy or breastfeeding on Sept. 29, 2021. The statement reiterated the importance of vaccination in preventing severe illness and death resulting from COVID-19. It also highlighted the wide gap in vaccination rates with pregnant people who are less than half as likely […]